117 related articles for article (PubMed ID: 9322601)
1. Osteocalcin and osteonectin immunoreactivity in the diagnosis of osteosarcoma.
Fanburg JC; Rosenberg AE; Weaver DL; Leslie KO; Mann KG; Taatjes DJ; Tracy RP
Am J Clin Pathol; 1997 Oct; 108(4):464-73. PubMed ID: 9322601
[TBL] [Abstract][Full Text] [Related]
2. Osteocalcin and Osteonectin Expression in Canine Osteosarcoma.
Wehrle-Martinez AS; Dittmer KE; Aberdein D; Thompson KG
Vet Pathol; 2016 Jul; 53(4):781-7. PubMed ID: 26926085
[TBL] [Abstract][Full Text] [Related]
3. Osteocalcin and osteonectin immunoreactivity in extraskeletal osteosarcoma: a study of 28 cases.
Fanburg-Smith JC; Bratthauer GL; Miettinen M
Hum Pathol; 1999 Jan; 30(1):32-8. PubMed ID: 9923924
[TBL] [Abstract][Full Text] [Related]
4. Submicroscopic and immunohistochemical profile of surface osteosarcomas.
Franchi A; Comin CE; Santucci M
Ultrastruct Pathol; 1999; 23(4):233-40. PubMed ID: 10503742
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the presence of osteocalcin, S-100 protein, and proliferating cell nuclear antigen in cells of various types of osteosarcomas.
Chano T; Matsumoto K; Ishizawa M; Morimoto S; Hukuda S; Okabe H; Kato H; Fujino S
Eur J Histochem; 1996; 40(3):189-98. PubMed ID: 8922947
[TBL] [Abstract][Full Text] [Related]
6. Osteonectin in osteosarcomas: a marker for differential diagnosis and/or prognosis?
Wuisman P; Roessner A; Bosse A; Ueda Y; Winkelmann W; Enneking WF
Ann Oncol; 1992 Apr; 3 Suppl 2():S33-5. PubMed ID: 1622861
[TBL] [Abstract][Full Text] [Related]
7. Vimentin, osteocalcin and osteonectin expression in canine primary bone tumors: diagnostic and prognostic implications.
Amaral CB; Leite JDS; Fonseca ABM; Ferreira AMR
Mol Biol Rep; 2018 Oct; 45(5):1289-1296. PubMed ID: 30066297
[TBL] [Abstract][Full Text] [Related]
8. Osteocalcin expression in primary bone tumors--in situ hybridization and immunohistochemical study.
Park YK; Yang MH; Kim YW; Park HR
J Korean Med Sci; 1995 Aug; 10(4):263-8. PubMed ID: 8593206
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of osteonectin as a diagnostic marker of osteogenic bone tumors.
Serra M; Morini MC; Scotlandi K; Fisher LW; Zini N; Colombo MP; Campanacci M; Maraldi NM; Olivari S; Baldini N
Hum Pathol; 1992 Dec; 23(12):1326-31. PubMed ID: 1468768
[TBL] [Abstract][Full Text] [Related]
10. [Immunohistochemical localization of bone Gla protein and osteonectin in normal human bone and cartilage tissues, and in osteosarcomas and chondrosarcomas].
Chiba H; Matsuyama T
Nihon Seikeigeka Gakkai Zasshi; 1993 May; 67(5):463-72. PubMed ID: 8336066
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of bone GLA protein in primary bone tumors.
Iwasaki R; Yamamuro T; Kotoura Y; Okumura H; Kasai R; Nakashima Y
Cancer; 1992 Aug; 70(3):619-24. PubMed ID: 1320449
[TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical identification of osteogenic bone tumors by osteonectin antibodies.
Jundt G; Schulz A; Berghäuser KH; Fisher LW; Gehron-Robey P; Termine JD
Virchows Arch A Pathol Anat Histopathol; 1989; 414(4):345-53. PubMed ID: 2496522
[TBL] [Abstract][Full Text] [Related]
13. The impact of osteonectin for differential diagnosis of bone tumors. An immunohistochemical approach.
Bosse A; Vollmer E; Böcker W; Roessner A; Wuisman P; Jones D; Fisher LW
Pathol Res Pract; 1990 Oct; 186(5):651-7. PubMed ID: 2287591
[TBL] [Abstract][Full Text] [Related]
14. Analysis of mutant P53 protein in osteosarcomas and other malignant and benign lesions of bone.
Ueda Y; Dockhorn-Dworniczak B; Blasius S; Mellin W; Wuisman P; Böcker W; Roessner A
J Cancer Res Clin Oncol; 1993; 119(3):172-8. PubMed ID: 8418091
[TBL] [Abstract][Full Text] [Related]
15. [Bone matrix production in osteosarcoma].
Schulz A; Loreth B; Battmann A; Knoblauch B; Stahl U; Pollex U; Bohle RM
Verh Dtsch Ges Pathol; 1998; 82():144-53. PubMed ID: 10095426
[TBL] [Abstract][Full Text] [Related]
16. Histomorphometry of active osteoblast surface labelled by antibodies against non-collagenous bone matrix proteins.
Hinrichs B; Dreyer T; Battmann A; Schulz A
Bone; 1993; 14(3):469-72. PubMed ID: 8363894
[No Abstract] [Full Text] [Related]
17. Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures.
Malaval L; Modrowski D; Gupta AK; Aubin JE
J Cell Physiol; 1994 Mar; 158(3):555-72. PubMed ID: 8126078
[TBL] [Abstract][Full Text] [Related]
18. Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro.
Garnero P; Grimaux M; Seguin P; Delmas PD
J Bone Miner Res; 1994 Feb; 9(2):255-64. PubMed ID: 8140939
[TBL] [Abstract][Full Text] [Related]
19. Use of alkaline phosphatase staining to differentiate canine osteosarcoma from other vimentin-positive tumors.
Barger A; Graca R; Bailey K; Messick J; de Lorimier LP; Fan T; Hoffmann W
Vet Pathol; 2005 Mar; 42(2):161-5. PubMed ID: 15753469
[TBL] [Abstract][Full Text] [Related]
20. Pathological diagnosis of osteosarcoma: the validity of the subclassification and some new diagnostic approaches using immunohistochemistry.
Ueda Y; Roessner A; Grundmann E
Cancer Treat Res; 1993; 62():109-24. PubMed ID: 8096725
[No Abstract] [Full Text] [Related]
[Next] [New Search]
